Bioanalytical Services
 |
PharmaNet offers bioanalytical laboratory services through its subsidiaries: Anapharm, Anapharm Europe, Keystone Analytical and Taylor Technology.
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
 |
 |
 |
 |
 |
| Octreotide | Endocrinology | LC/MS/MS | 50-4000 pg/mL | Human EDTA Plasma |
| Octreotide | Endocrinology | LC/MS/MS | 0.25-5 ng/mL | Rat EDTA Plasma |
| O-desmethyltramadol | Pain | LC/MS/MS | 1-100 ng/mL | Human Plasma |
| Ofloxacin | Infectious Disease | HPLC/FLR | 5-5000 ng/mL | Human EDTA Plasma |
| o-hydroxy-atorvastatin | Cardiovascular | LC/MS/MS | 0.25-100 ng/mL ; 0.25-20 ng/mL ; 0.25-100 ng/mL | Human Sodium Heparin Plasma |
| Olanzapine | Central Nervous System Agents | LC/MS/MS | 0.1-20 ng/mL | Human EDTA Plasma |
| Olmesartan | Cardiovascular | LC/MS/MS | 3-1500 ng/mL | Human Plasma |
| Omeprazole | Gastrointestinal | LC/MS/MS | 5-1000 ng/mL | Human EDTA Plasma |
| Omeprazole | Gastrointestinal | LC/MS/MS | 2-1000 ng/ml | Human ETDA K2 Plasma |
| Ondansetron | Gastrointestinal | LC/MS/MS | 0.5-200 ng/mL | Human EDTA Plasma |
| Ondansetron | Gastrointestinal | LC/MS | 10-1000 ng/mL | Human Lithium Heparin Plasma |
| Opipramol | Central Nervous System Agents | LC/MS/MS | 100-40000 pg/mL | Human EDTA Plasma |
| Orlistat | Endocrinology/Metabolism | LC/MS/MS | 10-4000 pg/mL | Human EDTA Plasma |
| Oxandrolone | Endocrinology | LC/MS/MS | 0.2-20 ng/mL | Human EDTA Plasma |
| Oxcarbazepine; 10-Hydroxycarbamazepine | Central Nervous System Agents | LC/MS/MS | 4-2000 ng/mL; 20-10000ng/mL | Human EDTA Plasma |
| Oxcarbazepine; 10-Hydroxycarbamazepine | Central Nervous System Agents | LC/MS/MS | 5-2500 ng/mL ; 30-15000 ng/mL | Human EDTA Plasma |
| Oxybutazone | Pain | HPLC/UV | 0.1-50 µg/mL | Horse Plasma |
| Oxybutynin; N-Desethyloxybutynin | Genitourinary | LC/MS/MS | 50-10000 pg/mL ; 100-20000 pg/mL | Human Sodium Heparinized Plasma |
| Oxybutynin; N-Desethyloxybutynin | Genitourinary | LC/MS/MS | 50-10000 pg/mL | Human EDTA Plasma |
| Oxycodone | Pain | LC/MS/MS | 0.25-125 ng/mL | Human EDTA Plasma |
| Oxycodone | Pain | LC/MS/MS | 0.25-90 ng/mL | Human EDTA Plasma |
| Oxycodone | Pain | LC/MS/MS | 100-25000 ng/mL | Human Plasma |
| Oxycodone metabolite: Nor-oxymorphone | Pain | LC/MS/MS | 0.25-50 ng/mL | Human Plasma |
| Oxymorphone | Pain | LC/MS/MS | 0.1-20 ng/mL | Human EDTA Plasma |
| Oxymorphone metabolite: 6-OH Oxymorphone | Pain | LC/MS/MS | 0.1-20 ng/mL | Human EDTA Plasma |
| Oxypurinol | Rheumatology | LC/MS/MS | 25-2000 ng/mL | Human EDTA Plasma |